conflicting interests, drug research, drug companies,
To what degree do financial entanglements influence the judgment of scientists? To find out, researchers at the Mayo Clinic in Rochester, Minn., focused on the diabetes drug rosiglitazone, which a meta-analysis had linked to increased risk of heart attacks. They examined articles that cited the meta-analysis or a subsequently released report on a large trial of rosiglitazone and found that scientists with a conflict of interest were more likely to view the drug favorably. “There was a clear and strong link between the orientation of authors' expressed views on the rosiglitazone controversy and their financial conflicts of interest with pharmaceutical companies,” the report determined.